Hartfalen: onderschatte sluipmoordenaar

Bui AL, Horwich TB, Fonarow GC; Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8:30–41

Brenner H, Bouvier AM, Foschi R et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study. Int J Cancer. 2012; 131: 1649–1658.

Coleman MP, Forman D, Bryant H et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011; 377: 127–138.

Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland, JH, Stein, KD, Alteri, R, Jemal, A. Cancer treatment and survivorship statistics, 2016. CA: A Cancer Journal for Clinicians.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. doi: 10.1093/eurheartj/ehw128 2016. Te vinden op http://www.escardio.org .

Ambrosy PA et al. The Global Health and Economic Burden of Hospitalizations for Heart Failure. Lessons Learned From Hospitalized Heart Failure Registries. J Am Coll Cardiol. 2014;63:1123–1133.

Zie figuur 4.2 blz. 59 in ‘Zorg rondom hartfalen’, Tiny Jaarsma en Martje van der Wal. Uitgeverij Bohn Stafleu van Loghum, 2015 ISBN: 9789036806589